A novel splicing CYLD variant associated with trichoepithelioma papulosum multiplex demonstrating intrafamilial severity variability
The Journal of Dermatology · 2024
DOI: 10.1111/1346-8138.17182 ↗Kurz gefasst
Leserbrief in der Zeitschrift The Journal of Dermatology, 2024. Verfasst von Ryo Fukaura und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan. Hauptthemen laut MEDLINE: Deubiquitinating Enzyme CYLD, Skin Neoplasms. Die Arbeit nennt 4 Literaturangaben. Gefördert von: Ministry of Health, Labour and Welfare.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
- Department of Dermatology, Asahi University Hospital, Gifu, Japan.
- Department of Dermatology, Gifu University Graduate School of Medicine, Gifu, Japan.
ORCID-Profile: Ryo Fukaura, Takuya Takeichi, Yoshinao Muro, Masashi Akiyama
Förderung
- Ministry of Health, Labour and Welfare
Zitieren
APA
Fukaura, R., Takeichi, T., Noda, T., Seishima, M., Muro, Y., & Akiyama, M. (2024). A novel splicing CYLD variant associated with trichoepithelioma papulosum multiplex demonstrating intrafamilial severity variability. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.17182
Vancouver
Fukaura R, Takeichi T, Noda T, Seishima M, Muro Y, Akiyama M. A novel splicing CYLD variant associated with trichoepithelioma papulosum multiplex demonstrating intrafamilial severity variability. The Journal of Dermatology. 2024. doi:10.1111/1346-8138.17182
BibTeX
@article{Fukaura2024,
author = {Fukaura, Ryo and Takeichi, Takuya and Noda, Tatsuhiro and Seishima, Mariko and Muro, Yoshinao and Akiyama, Masashi},
title = {A novel splicing CYLD variant associated with trichoepithelioma papulosum multiplex demonstrating intrafamilial severity variability},
journal = {The Journal of Dermatology},
year = {2024},
doi = {10.1111/1346-8138.17182}
}
EUVIMED